2 weeks Ago By ABMN Staff
Russell Investments Group Ltd. lifted its stake in shares of Orthofix Medical Inc. ( NASDAQ:OFIX – Free Report ) by 2.
6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 170,573 shares of the medical device company’s stock after purchasing an additional 4,329 shares during the quarter. Russell Investments Group Ltd.
owned about 0.45% of Orthofix Medical worth $2,978,000 at the end of the most recent reporting period. Other hedge funds and other institutional investors have also added to or reduced their stakes in the company.
Franklin Resources Inc. grew its stake in Orthofix Medical by 37.4% in the third quarter.
Franklin Resources Inc. now owns 20,960 shares of the medical device company’s stock valued at $337,000 after acquiring an additional 5,702 shares during the period. Barclays PLC lifted its holdings in shares of Orthofix Medical by 38.
8% in the 3rd quarter. Barclays PLC now owns 122,472 shares of the medical device company’s stock worth $1,912,000 after purchasing an additional 34,210 shares in the last quarter. Kirr Marbach & Co.
LLC IN acquired a new stake in Orthofix Medical in the 4th quarter valued at $532,000. JPMorgan Chase & Co. increased its stake in Orthofix Medical by 480.
7% during the 3rd quarter. JPMorgan Chase & Co. now owns 84,379 shares of the medical device company’s stock valued at $1,318,000 after purchasing an additional 69,848 shares in the last quarter.
Finally, Raymond James Financial Inc. bought a new stake in Orthofix Medical during the 4th quarter valued at $1,003,000. 89.
76% of the stock is owned by institutional investors. Analysts Set New Price Targets OFIX has been the subject of a number of analyst reports. Roth Mkm reiterated a “buy” rating and set a $22.
00 price objective on shares of Orthofix Medical in a report on Wednesday, February 26th. Canaccord Genuity Group reiterated a “buy” rating and set a $24.00 price target on shares of Orthofix Medical in a research note on Wednesday, February 26th.
Finally, StockNews.com raised Orthofix Medical from a “hold” rating to a “buy” rating in a report on Tuesday, February 25th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock.
Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $23.33. Orthofix Medical Stock Up 0.
5 % OFIX opened at $13.03 on Friday. Orthofix Medical Inc.
has a fifty-two week low of $12.08 and a fifty-two week high of $20.73.
The firm has a market capitalization of $508.46 million, a P/E ratio of -4.16 and a beta of 0.
99. The company’s 50-day moving average is $16.35 and its 200 day moving average is $17.
16. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.
39 and a quick ratio of 1.11. Insiders Place Their Bets In other news, insider Lucas Vitale sold 4,287 shares of the company’s stock in a transaction that occurred on Tuesday, March 18th.
The stock was sold at an average price of $16.60, for a total value of $71,164.20.
Following the completion of the transaction, the insider now directly owns 135,317 shares of the company’s stock, valued at $2,246,262.20. This represents a 3.
07 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink . Insiders have sold a total of 5,426 shares of company stock valued at $90,919 in the last 90 days.
2.60% of the stock is currently owned by corporate insiders. Orthofix Medical Profile ( Free Report ) Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally.
It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. Further Reading Want to see what other hedge funds are holding OFIX? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Orthofix Medical Inc. ( NASDAQ:OFIX – Free Report ). Receive News & Ratings for Orthofix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix Medical and related companies with MarketBeat.
com's FREE daily email newsletter ..
